HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Treatment Group:
- People who are receiving care for HIV at one of the twelve participating clinics in the DC Cohort
- People who are 18 years old or older, or younger people who manage their own HIV care independently and are able to understand and sign a consent form
- Younger people (minors) whose parent or legal guardian provides consent on their behalf
Prevention Group:
- People who are taking HIV prevention or post-exposure medications (such as PrEP medications like TDF/FTC, Descovy, or Apretude) without having HIV or Hepatitis B themselves
- People taking a medication called Doxycycline within 72 hours after unprotected sex as a prevention measure (sometimes called DoxyPEP), where it is clearly not being used as a treatment course
- People who have tested positive for one or more bacterial sexually transmitted infections (such as gonorrhoea, chlamydia, or syphilis requiring treatment) in the past year, with at least two STI tests and two HIV tests across separate visits
- People who ask their doctor about starting PrEP or post-exposure prevention medications at a clinic visit
- People who identify as injecting drug users
- People whose medical record includes a specific code for an HIV prevention consultation (confirm with trial site)
Who may not be able to join:
- People who are unable to provide informed consent, or who choose not to
- Young people aged 12 to 17 who do not know their own HIV status
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amanda D Castel, MD, MPH, George Washington University
Phone: 202-994-8325
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
viral suppression among persons with HIV; clinical outcomes persons at higher risk for acquiring HIV
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.